Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Problemi correnti

PDF

Uso di immunoglobuline e rischio di epatite C

HEPATITIS C INFECTION IN PATIENTS TREATED WITH CONTAMINATED IMMUNE GLOBULIN

GIORGIO BARTOLOZZI

Dipartimento di Pediatria, Università di Firenze

Giugno 1997 - pagg. 369 -370

Abstract
Recently HCV infection has been reported in association with administration of parenteral immunoglobulin. In some patients HCV infection was associated with severe, acute course, attributable to host factors, such as immunodeficiencies. Many of these patients developed chronic infection. Although this is a rare event, paediatricians schould be aware of this risk, carry on an active surveillance and notify all suspect cases.
Parole chiave
IT Epatite immunoglobulina
EN HCV Hepatitis Immunoglobulin
Suggerite dall'AI
IT Epatite C
EN Hepatitis C Immunodeficiency
Classificazione MeSH
Drug Contamination (4) Hepacivirus (4) Hepatitis C (26) Immunoglobulins, Intravenous (103) Immunologic Deficiency Syndromes (50) Product Surveillance, Postmarketing (4)
Leggi anche
RI Casi indimenticabili
Due fratelli con infezione da epatite C: i farmaci DAA
Mainetti M, Turlà G, Rametta G, Marchetti F. · 2025
Hepacivirus, Hepatitis C
RI Ricerca
La trasmissione perinatale dell’HCV
M. Resti e coll. · 1998
Hepacivirus, Hepatitis C, Immunologic Deficiency Syndromes/HIV Infections
EL I Poster degli specializzandi
Otiti ricorrenti? Fatti gli anticorpi… se li hai!
A. Boncompagni, F. Felici, I. Fontana, S. Fornacia · 2018
Immunologic Deficiency Syndromes, Immunoglobulins, Intravenous
Leggi il PDF completo »

Bibliografia

1. Jonas MM, Baron MJ, Bresee JS, Schneider LC: Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Pediatrics 98, 211-5, 1996.
2. Healey JH, Sabharval NK, Daub J et al: Outbreak of acute hepatitis C following the use of anti-hepatitis C virus-screening intravenous immunoglobulin therapy. Gastroenterology 110, 1120-6, 1996.
3. Flora K, Schiele M, Benner K et al: An outbreak of acute hepatitis C among recipients of intravonous immunoglobulin. Ann Allergy Asthma Immunol 76, 160-2, 1996. 4.CDC: Outbreak of hepatitis C, associated with intravenous immunoglobulin administration - United States, ottobre 1993 - giugno
1994. MMWR 43, 505-9, 1994.
5. Power JP, Lawlor E, Davidson F et al: Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin. Lancet 344, 1166-7, 1994.